Trials / Completed
CompletedNCT06031675
Mechanism for Exercise to Delay Cardiac Aging
The αKlotho Protein-mediated NLRP3/Caspase-1/GSDMD Pathway Counteracts Myocardial Stunning: a Novel Mechanism for Exercise to Delay Cardiac Aging
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Xiao-dong Zhuang · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinicaltrial is to assess and compare isokinetic performance, surface electromyography, laboratory parameters, and cardiorespiratory function both before and after engaging in vigorous intermittent lifestyle physical activity(VILPA) within a healthy population. The main question it aims to answer is: \[1\] Does VILPA yield effective outcomes? Throughout the course of the trial, participants will engage in a simulated regimen of vigorous intermittent lifestyle physical activity for a duration of 8 weeks. The efficacy of the exercise protocol will be quantified and evaluated through the utilization of a wearable device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Vigorous intermittent lifestyle physical activity | The specific exercise regimen involves performing rope jumping activities three times a day, with each session aimed at surpassing the exercise threshold (not conducted in a continuous manner), where the heart rate should exceed 160 beats per minute. This routine will be undertaken five times a week, continuously for a span of 8 weeks. |
Timeline
- Start date
- 2023-05-12
- Primary completion
- 2023-07-10
- Completion
- 2023-09-01
- First posted
- 2023-09-11
- Last updated
- 2023-09-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06031675. Inclusion in this directory is not an endorsement.